Sara Bonstein - Jan 6, 2022 Form 4 Insider Report for INSMED Inc (INSM)

Role: Chief Financial Officer
Signature: /s/ Sara Bonstein, by Michael Smith as Attorney in Fact
Stock symbol: INSM
Transactions as of: Jan 6, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/10/2022, 04:08 PM
Previous filing: Oct 21, 2021
Next filing: Jan 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INSM	Common Stock	Award		+13K	+53.91%		37.1K	Jan 6, 2022	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INSM	Stock Option (right to buy)	Award	$0	+62.8K		$0.00	62.8K	Jan 6, 2022	Common Stock	62.8K	$26.43	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.
F2	Each Restricted Stock Unit was received as a grant on January 6, 2022, for no consideration.
F3	Includes 772 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
F4	Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.